Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,002 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03418038 | Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | recruiting | Phase 2 | 80 | Mayo ClinicOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT05288062 | Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma | terminated | Phase 2 | 17 | Mayo ClinicOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT06472817 | Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men | enrolling by invitation | — | 80 | Mayo ClinicOTHER | 1 | Sep 28, 2026 | clinicaltrials |
| NCT01727284 | MR-Guided Cryoablation of Prostate Bed Recurrences | enrolling by invitation | N/A | 200 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT02649387 | Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy(MERIT) | completed | Phase 2 | 35 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06106295 | Metyrapone for Mild Autonomous Cortisol Secretion (MACS) | active not recruiting | Phase 2 | 30 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06369610 | Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer | active not recruiting | Phase 2 | 110 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT06855524 | Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer | recruiting | Phase 2 | 34 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07126548 | A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men | recruiting | N/A | 200 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT07138274 | Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS | recruiting | Phase 2 | 90 | Mayo ClinicOTHER | 1 | Sep 25, 2026 | clinicaltrials |
| NCT02860000 | Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer | completed | Phase 2 | 96 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT03220893 | Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast Tissue | completed | N/A | 3,023 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT04570956 | Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk | terminated | Phase 2 | 65 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT05575440 | Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer | terminated | — | 11 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT06911008 | MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers | recruiting | Phase 1 | 42 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT07100990 | Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)(TIMELY-PLEX) | recruiting | Phase 3 | 382 | Mayo ClinicOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT05733312 | Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption | recruiting | N/A | 6 | Mayo ClinicOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT06999798 | An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial | recruiting | Phase 1 | 20 | Mayo ClinicOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT07708961 | Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma | suspended | Phase 2 | 60 | Mayo ClinicOTHER | 1 | Sep 23, 2026 | clinicaltrials |
| NCT03197506 | Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | active not recruiting | Phase 2 | 52 | Mayo ClinicOTHER | 1 | Sep 22, 2026 | clinicaltrials |
| NCT03471364 | Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash | completed | Early Phase 1 | 58 | Mayo ClinicOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT05920798 | Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer(FRAPPE) | active not recruiting | Phase 1 / Phase 2 | 38 | Mayo ClinicOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT06271291 | Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts | recruiting | — | 30,000 | Mayo ClinicOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT07823283 | Continuous Monitoring of Microvascular Anastomoses: An Observational Trial | recruiting | — | 100 | Mayo ClinicOTHER | 1 | Sep 21, 2026 | clinicaltrials |
| NCT05077735 | Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial | active not recruiting | Phase 2 | 17 | Mayo ClinicOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT07650240 | Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial(SPARKLE) | recruiting | Phase 2 | 202 | Mayo ClinicOTHER | 1 | Sep 18, 2026 | clinicaltrials |
| NCT06205316 | SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma | active not recruiting | Phase 3 | 118 | Mayo ClinicOTHER | 1 | Sep 17, 2026 | clinicaltrials |
| NCT06630338 | Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements | not yet recruiting | — | 30 | Mayo ClinicOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT06274034 | MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors | terminated | Early Phase 1 | 14 | Mayo ClinicOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT04858009 | Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis | recruiting | Phase 2 | 40 | Mayo ClinicOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06192875 | A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study) | recruiting | — | 10,000 | Mayo ClinicOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06674811 | Biomarkers of Resiliency In Childhood Cancer Surgery(BRICCS) | recruiting | — | 40 | Mayo ClinicOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT07644702 | WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income Women | terminated | N/A | 1 | Mayo ClinicOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06940271 | Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy(RAP) | recruiting | N/A | 45 | Mayo ClinicOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07062003 | Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors | recruiting | N/A | 60 | Mayo ClinicOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07729384 | Strengthening Teen Brain Resilience Using Music Intervention to Improve Radiation Induced Cognitive Decline for Adolescents Undergoing Radiation Therapy for Cancer Treatment | not yet recruiting | N/A | 30 | Mayo ClinicOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07810400 | A Study Of Remote Patient Monitoring (RPM) Program For Cancer Patients Initiating Cancer-directed Therapy | not yet recruiting | N/A | 470 | Mayo ClinicOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT04816006 | Breast Cancer, Reasoning, and Activity Intervention(BRAIN) | recruiting | N/A | 160 | Mayo ClinicOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT06482073 | Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care | recruiting | — | 250 | Mayo ClinicOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT07805083 | Community Enhanced Virtual Informed Consent(CEVIC) | recruiting | N/A | 600 | Mayo ClinicOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT04493060 | Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer | completed | Phase 2 | 22 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06055881 | Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy(BOSS) | active not recruiting | N/A | 45 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06470750 | Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP) | completed | — | 75 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06635980 | Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer | recruiting | Phase 2 | 120 | Mayo ClinicOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06198010 | A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors(ASCENT) | active not recruiting | N/A | 680 | Mayo ClinicOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT06557057 | Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk | recruiting | — | 81 | Mayo ClinicOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07565974 | THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia | not yet recruiting | Phase 2 | 69 | Mayo ClinicOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT03021460 | Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery | completed | Phase 1 | 20 | Mayo ClinicOTHER | 1 | Sep 1, 2026 | clinicaltrials |
Data updated 20 hours agoSource updated unknownsource: clinicaltrials